LifeMD (LFMD) Total Non-Current Liabilities (2019 - 2025)

LifeMD has reported Total Non-Current Liabilities for 7 years, with the latest figure at $62.5 million in Q3 2025.

• For the quarter ending Q3 2025, Total Non-Current Liabilities fell 20.28% year-over-year to $62.5 million; the trailing twelve-month figure through Sep 2025 stood at $62.5 million (down 20.28% YoY), and the FY2024 full-year result was $83.6 million, up 58.29% from the prior year.
• Total Non-Current Liabilities for Q3 2025 stood at $62.5 million, down from $73.1 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $83.6 million in Q4 2024, with the low at $24.0 million in Q4 2021.
• Historically, Total Non-Current Liabilities has averaged $51.7 million across 5 years, with a median of $52.2 million in 2023.
• Annual changes were most pronounced in 2023 — Total Non-Current Liabilities jumped 89.7% — and 2025, when it declined 20.28%.
• LifeMD's Total Non-Current Liabilities stood at $24.0 million in 2021, then soared by 35.51% to $32.5 million in 2022, then soared by 62.27% to $52.8 million in 2023, then soared by 58.29% to $83.6 million in 2024, then fell by 25.18% to $62.5 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $62.5 million (Q3 2025), $73.1 million (Q2 2025), and $73.9 million (Q1 2025), per Business Quant data.